Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71205-468

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71205-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)

Chemical structure of TRAMADOL HYDROCHLORIDE, showing its molecular arrangement with functional groups including a hydroxyl group and aromatic ring with methoxy substitution, along with the hydrochloride component.*

FDA Label Image

Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)

A line graph showing Tramadol concentration (ng/mL) in blood plasma over 24 hours following administration. The x-axis represents time in hours, and the y-axis shows Tramadol concentration. Two lines compare Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily and Tramadol Hydrochloride Tablets 50 mg taken every 6 hours, illustrating differences in plasma concentration profiles over time.*

FDA Label Image

Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)

A line graph comparing the M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration in ng/mL. Two curves with distinct markers illustrate concentration fluctuations during the dosing intervals.*

FDA Label Image

Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold (percent improvement from baseline). The graph compares five treatment groups: Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, 400 mg, and placebo. The x-axis represents response threshold percentages from 0 to 100, and the y-axis shows the percent of patients achieving response from 0 to 60 percent.*

FDA Label Image

Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing percent of patients achieving response thresholds. The x-axis represents response threshold as percent improvement from baseline (0 to 100), and the y-axis shows percent of patients achieving response (0 to 60%). Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, indicating higher response rates for Tramadol across thresholds.*

FDA Label Image

71205-468-30 (33a5de83 A974 48a5 8ba6 4c1b97515615 07)

Label for Tramadol HCl 200 mg extended-release tablets from Proficient Rx LP. The package contains 30 tablets, to be taken once daily. Tablets are described as white to off-white, biconvex, beveled edge, coated with imprint 'L011'. Manufactured by Lupin Limited in India. Includes NDC 71205-468-30 and Rx only C-IV designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.